Company Overview

PRIME exits and American Healthcare Capital are pleased to exclusively represent a well-established drug and alcohol treatment center located in the Southwest United States. The company is a leading provider of comprehensive services, including detoxification, inpatient treatment, outpatient programs, and sober living accommodations. Fully accredited by the Joint Commission, the business is committed to delivering the highest standards of care and safety.

Financial Overview

The company’s payer mix is as follows:

• Commercial Insurance: Approximately 90-95%

• Private Pay: Approximately 5-10%

The company has demonstrated steady growth over the past four years:

• 2022: Gross Revenue of $7,200,000 | Adjusted EBITDA of $2,800,000

• 2023: Gross Revenue of $8,500,000 | Adjusted EBITDA of $3,400,000

• 2024: Gross Revenue of $9,000,000 | Adjusted EBITDA of $3,200,000

The company is well-positioned to capitalize on favorable trends in the behavioral health market, offering significant growth opportunities for a new owner. However, the business is at a pivotal juncture. One of the owners has fallen ill and has decided to sell, but the other owner is healthy and open to remaining post-acquisition. Additionally, a strong leadership team is in place to ensure a seamless transition for the buyer.

Asking Price

The asking price for this opportunity is $21 million, which does not include cash, receivables, working capital, or real estate. The real estate is available for purchase separately.